<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37261630</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>3567</StartPage><EndPage>3575</EndPage><MedlinePgn>3567-3575</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06860-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Currently, miRNAs are involved in the development of amyotrophic lateral sclerosis (ALS), and identifying circulating miRNAs that are causally associated with ALS risk as biomarkers is imperative.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a two-sample Mendelian randomization study to evaluate the causal relationship between miRNAs and ALS. Our analysis was conducted using summary statistics from miRNA expression quantitative loci (eQTL) data of the Framingham Heart Study and ALS genome-wide association studies data. Another independent miRNA data was used to further validate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified eight unique miRNAs that were causally associated with ALS risk. Using expression data of miRNAs from an independent study, we validated three high-confidence miRNAs, namely hsa-miR-27b-3p, hsa-miR-139-5p, and hsa-miR-152-3p, which might have a potential causal effect on ALS risk.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We suggested that higher levels of hsa-miR-27b-3p and hsa-miR-139-5p had protective effects on ALS, whereas higher levels of hsa-miR-152-3p might act as a risk factor for ALS. The analytical framework presented in this study helps to understand the role of miRNAs in the development of ALS and to identify the biomarkers for ALS risk.</AbstractText><CopyrightInformation>&#xa9; 2023. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yahui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical School of Chinese PLA, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhengqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Medical School of Chinese PLA, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Xinyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Nankai University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Rongrong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Nankai University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wenxiu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Medical School of Chinese PLA, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinghong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical School of Chinese PLA, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Jiongming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Nankai University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical School of Chinese PLA, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xusheng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2451-0254</Identifier><AffiliationInfo><Affiliation>Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing, China. lewish301@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074166">Circulating MicroRNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C555098">MIRN139 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C550856">MIRN152 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074166" MajorTopicYN="Y">Circulating MicroRNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37261630</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06860-3</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06860-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bucchia M, Ramirez A, Parente V, Simone C, Nizzardo M, Magri F, Dametti S, Corti S (2015) Therapeutic development in amyotrophic lateral sclerosis. Clin Ther 37(3):668&#x2013;680. https://doi.org/10.1016/j.clinthera.2014.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.12.020</ArticleId><ArticleId IdType="pubmed">25666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier F, Marrero A, O'Connell C, Morin P Jr (2015) MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis. J Mol Neurosci 56(1):102&#x2013;112. https://doi.org/10.1007/s12031-014-0471-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0471-8</ArticleId><ArticleId IdType="pubmed">25433762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T (2015, 1852) Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta (4):679&#x2013;684. https://doi.org/10.1016/j.bbadis.2014.08.010</Citation></Reference><Reference><Citation>Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E (2014) Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci 71(6):999&#x2013;1015. https://doi.org/10.1007/s00018-013-1480-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1480-4</ArticleId><ArticleId IdType="pubmed">24100629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41(2):118&#x2013;130. https://doi.org/10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7(11):603&#x2013;615. https://doi.org/10.1038/nrneurol.2011.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM (2013) Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology 33(2):122&#x2013;133. https://doi.org/10.1111/j.1440-1789.2012.01332.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2012.01332.x</ArticleId><ArticleId IdType="pubmed">22702520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA 109(9):3347&#x2013;3352. https://doi.org/10.1073/pnas.1112427109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId><ArticleId IdType="pmc">3295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19(R1):R46&#x2013;R64. https://doi.org/10.1093/hmg/ddq137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId><ArticleId IdType="pmc">3167692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ason B, Darnell DK, Wittbrodt B, Berezikov E, Kloosterman WP, Wittbrodt J, Antin PB, Plasterk RH (2006) Differences in vertebrate microRNA expression. Proc Natl Acad Sci USA 103(39):14385&#x2013;14389. https://doi.org/10.1073/pnas.0603529103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603529103</ArticleId><ArticleId IdType="pubmed">16983084</ArticleId><ArticleId IdType="pmc">1599972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281&#x2013;297. https://doi.org/10.1016/s0092-8674(04)00045-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(04)00045-5</ArticleId><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen BR (2006) Viruses and microRNAs. Nat Gen 38:S25&#x2013;S30. https://doi.org/10.1038/ng1793</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1793</ArticleId></ArticleIdList></Reference><Reference><Citation>Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Fo&#xe0; R, Schliwka J, Fuchs U, Novosel A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7):1401&#x2013;1414. https://doi.org/10.1016/j.cell.2007.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.04.040</ArticleId><ArticleId IdType="pubmed">17604727</ArticleId><ArticleId IdType="pmc">2681231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallory AC, Vaucheret H (2006) Functions of microRNAs and related small RNAs in plants. Nat Gen 38:S31&#x2013;S36. https://doi.org/10.1038/ng1791</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Lai EC (2013) Adult-specific functions of animal microRNAs. Nat Rev Genet 14(8):535&#x2013;548. https://doi.org/10.1038/nrg3471</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3471</ArticleId><ArticleId IdType="pubmed">23817310</ArticleId><ArticleId IdType="pmc">4136762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JY, Marques AC (2014) The miRNA-mediated cross-talk between transcripts provides a novel layer of posttranscriptional regulation. Adv Genet 85:149&#x2013;199. https://doi.org/10.1016/b978-0-12-800271-1.00003-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-800271-1.00003-2</ArticleId><ArticleId IdType="pubmed">24880735</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9(11):617&#x2013;628. https://doi.org/10.1038/nrneurol.2013.203</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7(11):639&#x2013;649. https://doi.org/10.1038/nrneurol.2011.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14(4):248&#x2013;264. https://doi.org/10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson R, Noble W, Tartaglia GG, Buckley NJ (2012) Neurodegeneration as an RNA disorder. Prog Neurobiol 99(3):293&#x2013;315. https://doi.org/10.1016/j.pneurobio.2012.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2012.09.006</ArticleId><ArticleId IdType="pubmed">23063563</ArticleId><ArticleId IdType="pmc">7116994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513&#x2013;10518. https://doi.org/10.1073/pnas.0804549105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804549105</ArticleId><ArticleId IdType="pubmed">18663219</ArticleId><ArticleId IdType="pmc">2492472</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Piscopo P, Confaloni A, Denti MA (2014) Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules (Basel, Switzerland) 19(5):6891&#x2013;6910. https://doi.org/10.3390/molecules19056891</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules19056891</ArticleId><ArticleId IdType="pubmed">24858274</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R Jr, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, Rohrer JD, Tartaglia MC, Robertson J (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89(8):851&#x2013;858. https://doi.org/10.1136/jnnp-2017-317492</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317492</ArticleId><ArticleId IdType="pubmed">29434051</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, Weydt P, Volk AE, Bo&#x17e;i&#x10d; AL, Walter M, Bonin M, Mayer B, von Arnim CA, Otto M, Dieterich C, Holzmann K, Andersen PM, Ludolph AC, Danzer KM, Weishaupt JH (2014) Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain 137(11):2938&#x2013;2950. https://doi.org/10.1093/brain/awu249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Huan T, Rong J, Liu C, Zhang X, Tanriverdi K, Joehanes R, Chen BH, Murabito JM, Yao C, Courchesne P, Munson PJ, O'Donnell CJ, Cox N, Johnson AD, Larson MG, Levy D, Freedman JE (2015) Genome-wide identification of microRNA expression quantitative trait loci. Nat Commun 6:6601. https://doi.org/10.1038/ncomms7601</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7601</ArticleId><ArticleId IdType="pubmed">25791433</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikpay M, Beehler K, Valsesia A, Hager J, Harper ME, Dent R, McPherson R (2019) Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes. Cardiovasc Res 115(11):1629&#x2013;1645. https://doi.org/10.1093/cvr/cvz030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz030</ArticleId><ArticleId IdType="pubmed">30715214</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt J, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya SBN, Marangi G et al (2018) Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97(6):1268&#x2013;1283.e1266. https://doi.org/10.1016/j.neuron.2018.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId><ArticleId IdType="pmc">5867896</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, V&#xf5;sa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP et al (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet 48(9):1043&#x2013;1048. https://doi.org/10.1038/ng.3622</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId><ArticleId IdType="pmc">5556360</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124:96&#x2013;107. https://doi.org/10.1016/0022-510x(94)90191-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical research ed) 362:k601. https://doi.org/10.1136/bmj.k601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k601</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker VM, Davey Smith G, Davies NM, Martin RM (2017) Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol 46(6):2078&#x2013;2089. https://doi.org/10.1093/ije/dyx207</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx207</ArticleId><ArticleId IdType="pubmed">29040597</ArticleId><ArticleId IdType="pmc">5837479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Zhou G, Soufan O, Xia J (2020) miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res 48(W1):W244&#x2013;w251. https://doi.org/10.1093/nar/gkaa467</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa467</ArticleId><ArticleId IdType="pubmed">32484539</ArticleId><ArticleId IdType="pmc">7319552</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, Tang Y, Chen YG, Jin CN, Yu Y, Xu JT, Li YM, Cai XX, Zhou ZY, Chen XH, Pei YY, Hu L, Su JJ, Cui SD et al (2020) miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res 48(D1):D148&#x2013;d154. https://doi.org/10.1093/nar/gkz896</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz896</ArticleId><ArticleId IdType="pubmed">31647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, Ikiz B, Hoffmann L, Koolen M, Nagata T, Papadimitriou D, Nagy P, Mitsumoto H, Kariya S, Wichterle H, Henderson CE, Przedborski S (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81(5):1001&#x2013;1008. https://doi.org/10.1016/j.neuron.2014.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId><ArticleId IdType="pmc">3951532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H, Chen H, Mayo L, Geng J, Amin P, DeWitt JP, Mookhtiar AK, Florez M, Ouchida AT, Fan JB, Pasparakis M, Kelliher MA et al (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science (New York, NY) 353(6299):603&#x2013;608. https://doi.org/10.1126/science.aaf6803</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice JR, Gregory-Evans CY, Shaw CA (2017) Necroptosis in amyotrophic lateral sclerosis and other neurological disorders. Biochim Biophys Acta Mol Basis Dis 1863(2):347&#x2013;353. https://doi.org/10.1016/j.bbadis.2016.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.11.025</ArticleId><ArticleId IdType="pubmed">27902929</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D'Errico E, Scarafino A, Distaso E, Simone IL (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288. https://doi.org/10.3389/fnmol.2018.00288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId><ArticleId IdType="pmc">6121079</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ (2013) Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain 6:26. https://doi.org/10.1186/1756-6606-6-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId><ArticleId IdType="pmc">3668997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley ZCE, Campos-Melo D, Strong MJ (2020) Evidence of a negative feedback network between TDP-43 and miRNAs dependent on TDP-43 nuclear localization. J Mol Biol 432(24):166695. https://doi.org/10.1016/j.jmb.2020.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.10.029</ArticleId><ArticleId IdType="pubmed">33137311</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R (2018) Correlating serum microRNAs and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve 58(2):261&#x2013;269. https://doi.org/10.1002/mus.26106</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita H, Yabe S, Ueda T, Inden M, Kakita A, Hozumi I (2020) MicroRNA-5572 is a novel microRNA-regulating SLC30A3 in sporadic amyotrophic lateral sclerosis. Int J Mol Sci 21(12):4482. https://doi.org/10.3390/ijms21124482</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124482</ArticleId><ArticleId IdType="pubmed">32599739</ArticleId><ArticleId IdType="pmc">7350020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai K, Liu B, Gao L (2020) Long-noncoding RNA TUG1 promotes Parkinson&#x2019;s disease via modulating MiR-152-3p/PTEN pathway. Hum Gene Ther 31(23-24):1274&#x2013;1287. https://doi.org/10.1089/hum.2020.106</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2020.106</ArticleId><ArticleId IdType="pubmed">32808542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A, Qian Y, Qian J (2019) MicroRNA-152-3p protects neurons from oxygen-glucose-deprivation/reoxygenation-induced injury through upregulation of Nrf2/ARE antioxidant signaling by targeting PSD-93. Biochem Biophys Res Commun 517(1):69&#x2013;76. https://doi.org/10.1016/j.bbrc.2019.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.07.012</ArticleId><ArticleId IdType="pubmed">31326116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>